Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA site-wide notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe 403 Forbidden page was replaced by the full study details content for NCT03695250, restoring access to the trial information.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content; a Home link is shown in the header.SummaryDifference20%

- Check48 days agoChange DetectedThe page revision changes from v3.6.6 to v3.7.0, indicating an updated version of the page. This appears to be a maintenance/version increment rather than a substantive change to study information.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor update to the page revision history.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.